Prosecution Insights
Last updated: October 04, 2026

Mbhb - Uw

Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering

11 pending office actions • 4 clients • 11 examiners • 8 art units • 0 of 11 (0%) have an AI response strategy ready • 22 patents granted in the last 365 days

Quality Metrics (n=621 apps, methodology: how we score firms)

79.5%
Allowance Rate
n=621
+0.71σ
Allowance Rate (norm)
n=621
3.2
OAs to Allowance
n=294
-0.26σ
OAs to Allow (norm)
n=294
1037 days
Time to Allowance
n=294
+22.2pp
Interview Lift
n=621
24.3%
RCE Rate
n=621
0.3%
Appeal Rate
n=621

Rejection Performance (% of received rejections ultimately overcome)

68.4%
§101 Overcome
n=79
81.5%
§102 Overcome
n=146
85.9%
§103 Overcome
n=184
78.8%
§112 Overcome
n=203

Specialization & Scale

C07K, A61K, C12N
Top CPC Subclasses
40%
Top-3 CPC Share
n=621
0
Practitioners
n=621
—
Apps / Practitioner
n=621 (min 20)

Portfolio Summary

11
Total Pending OAs
8
Non-Final OAs
3
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

1
Overdue
0
Due this week
2
Due this month
0
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (1)Due ≤ 30 days (2)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

5
Hard (45%)
1
Medium (9%)
5
Easy (45%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other5 (45%)
§103 only1 (9%)
§112 only4 (36%)
Double-patenting only1 (9%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

5
Life Sciences
45% of docket
0
Information Tech
0% of docket
1
Communications
9% of docket
0
Semiconductors
0% of docket
2
Mechanical / Eng
18% of docket
3
Business / Other
27% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

110 h
Manual time on pending OAs
22 h
Time saved (low, 20%)
38 h
Time saved (mid, 35%)
1.0 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
BANERJEE, KOYELI 1 50.0% +0.0%
KONOPELSKI SNAVEL, SARA ELIZABETH 1 33.3% +38.9%
KATAKAM, SUDHAKAR 1 74.7% +23.3%
KUDO, KEN 1 — —
YOON, CHANEL J 1 55.0% +40.1%
CHEN, STACY BROWN 1 66.1% +40.6%
HOWARD, ZACHARY C 1 64.0% +37.9%
TSAY, MARSHA M 1 45.7% +52.7%
KANE, TREVOR LOGAN 1 69.4% +52.5%
BLUMEL, BENJAMIN P 1 70.8% +30.5%

Hard Cases (5)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 5 ordered by deadline are shown.

App #TitleExaminerDue in
17760180 POLYPEPTIDES AND THEIR USE BLUMEL, BENJAMIN P 21d
18547897 Methods and Devices to Measure Angular Stiffness of Dental and Medical Implants YOON, CHANEL J 27d
18814954 Reagents and methods for treating bacterial infection BANERJEE, KOYELI —
18799107 De novo designed sequence-specific DNA binding proteins KONOPELSKI SNAVEL, SARA ELIZABETH —
18463683 Processing Images to Associate with Stages of a Surgical Procedure KUDO, KEN —

Interview Candidates (8)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
17938752 De novo designed protein homodimers containing tunable symmetric pockets TSAY, MARSHA M 169d overdue
17760180 POLYPEPTIDES AND THEIR USE BLUMEL, BENJAMIN P 21d
18547897 Methods and Devices to Measure Angular Stiffness of Dental and Medical Implants YOON, CHANEL J 27d
18799107 De novo designed sequence-specific DNA binding proteins KONOPELSKI SNAVEL, SARA ELIZABETH —
18576518 MULTIPLE DE NOVO DESIGNED PROTEIN BINDING PROTEINS KATAKAM, SUDHAKAR —
18360190 Glycoengineered protein nanoparticles and uses thereof CHEN, STACY BROWN —
18257719 Methods and Systems for Quantifying Lipoprotein(A) Using Candidate References HOWARD, ZACHARY C —
17931704 COMPOSITIONS AND METHODS FOR TREATING CELIAC SPRUE DISEASE KANE, TREVOR LOGAN —

Client Portfolio (4 clients)

Top Art Units

Art UnitApps
26711
37911
16721
16741
16561
16571
16711
37451

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
18814954 Reagents and methods for treating bacterial infection UNIVERSITY OF WASHINGTON BANERJEE, KOYELI §101§102§103§112DP Non-Final OA — Pending Aug 26, 2024
18799107 De novo designed sequence-specific DNA binding proteins UNIVERSITY OF WASHINGTON KONOPELSKI SNAVEL, SARA ELIZABETH §101§102§112 Non-Final OA — Pending Aug 09, 2024
18576518 MULTIPLE DE NOVO DESIGNED PROTEIN BINDING PROTEINS UNIVERSITY OF WASHINGTON KATAKAM, SUDHAKAR §112 Non-Final OA — Pending Jan 04, 2024
18463683 Processing Images to Associate with Stages of a Surgical Procedure Seattle Children'S Hospital D/B/A Seattle Children'S Research Institute KUDO, KEN 2671 §101§102§103§112 Non-Final OA — Pending Sep 08, 2023
18547897 Methods and Devices to Measure Angular Stiffness of Dental and Medical Implants UNIVERSITY OF WASHINGTON YOON, CHANEL J 3791 §101§102§103§112Other Final Rejection 27d Pending Aug 25, 2023
18360190 Glycoengineered protein nanoparticles and uses thereof UNIVERSITY OF WASHINGTON CHEN, STACY BROWN 1672 §112 Non-Final OA — Pending Jul 27, 2023
18257719 Methods and Systems for Quantifying Lipoprotein(A) Using Candidate References The University of Western Ontario HOWARD, ZACHARY C 1674 §112 Non-Final OA — Pending Jun 15, 2023
17938752 De novo designed protein homodimers containing tunable symmetric pockets UNIVERSITY OF WASHINGTON TSAY, MARSHA M 1656 §112 Non-Final OA 169d overdue Pending Oct 07, 2022
17931704 COMPOSITIONS AND METHODS FOR TREATING CELIAC SPRUE DISEASE The Regents of the University of California KANE, TREVOR LOGAN 1657 DP Non-Final OA — Pending Sep 13, 2022
17760180 POLYPEPTIDES AND THEIR USE UNIVERSITY OF WASHINGTON BLUMEL, BENJAMIN P 1671 §101§102§103§112 Final Rejection 21d Pending Aug 04, 2022
17775657 CLOSED-LOOP FEEDBACK FOR ADDITIVE MANUFACTURING SIMULATION UNIVERSITY OF WASHINGTON BUI, ANDREW THANH 3745 §103 Final Rejection — Pending May 10, 2022

Managing Mbhb - Uw's Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month